fluoxetine has been researched along with Allergic Encephalomyelitis in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Excerpt | Relevance | Reference |
---|---|---|
"This study was carried out to clarify the effects of the antidepressant fluoxetine, a selective serotonin reuptake inhibitor, for its potential use in autoimmune diseases like multiple sclerosis in a rat model of experimental autoimmune encephalomyelitis (EAE)." | 3.78 | Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats. ( Liu, S; Liu, XJ; Lu, T; Qiu, G; Wang, X; Wu, Y; Yuan, XQ, 2012) |
"The mice with experimental autoimmune encephalomyelitis exhibited exaggerated grooming activity." | 1.48 | Auto-Reactive Th17-Cells Trigger Obsessive-Compulsive-Disorder Like Behavior in Mice With Experimental Autoimmune Encephalomyelitis. ( Kant, R; Pasi, S; Surolia, A, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Akhavan Tavakoli, M | 1 |
Soleimani, M | 1 |
Marzban, H | 1 |
Shabani, R | 1 |
Moradi, F | 1 |
Ajdary, M | 1 |
Mehdizadeh, M | 1 |
Bhat, R | 1 |
Mahapatra, S | 1 |
Axtell, RC | 1 |
Steinman, L | 1 |
Kant, R | 1 |
Pasi, S | 1 |
Surolia, A | 1 |
Yuan, XQ | 1 |
Qiu, G | 1 |
Liu, XJ | 1 |
Liu, S | 1 |
Wu, Y | 1 |
Wang, X | 1 |
Lu, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
5-HTSEP: Serotonin 5-HT7 Receptor Implication in the Inflammatory Mechanisms in Multiple Sclerosis[NCT04546698] | 78 participants (Actual) | Observational | 2020-09-07 | Completed | |||
RESEPTOR 5-HT7 : Interest of the 5-HT7 Serotonin Receptor as a Biomarker in Multiple Sclerosis[NCT05746845] | 120 participants (Anticipated) | Observational | 2023-03-06 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for fluoxetine and Allergic Encephalomyelitis
Article | Year |
---|---|
Autophagic Molecular Alterations in the Mouse Cerebellum Experimental Autoimmune Encephalomyelitis Model Following Treatment with Cannabidiol and Fluoxetine.
Topics: Animals; Autophagy; bcl-2-Associated X Protein; Cannabidiol; Cerebellum; Encephalomyelitis, Autoimmu | 2023 |
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; CD11b Antigen; Cell Death; Cell Proliferation; Cytokin | 2017 |
Auto-Reactive Th17-Cells Trigger Obsessive-Compulsive-Disorder Like Behavior in Mice With Experimental Autoimmune Encephalomyelitis.
Topics: Adoptive Transfer; Animals; Autoimmunity; Behavior, Animal; Disease Models, Animal; Encephalomyeliti | 2018 |
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Encephalomyelitis, Autoimmune, Experimental; Fema | 2012 |
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Encephalomyelitis, Autoimmune, Experimental; Fema | 2012 |
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Encephalomyelitis, Autoimmune, Experimental; Fema | 2012 |
Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Encephalomyelitis, Autoimmune, Experimental; Fema | 2012 |